BIOMAT Database Logo BIOMAT Database Logo

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. 1992

R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Institute of Psychiatry, Medical University of South Carolina, Charleston 29425.

Cholecystokinin concentrations in the CSF of 25 patients with panic disorder and 16 normal comparison subjects were ascertained by radioimmunoassay. The patients with panic disorder had significantly lower CSF concentrations of cholecystokinin, which may reflect increased CNS cholecystokinin receptor sensitivity, reduced numbers of receptors, or a compensatory reduction in cholecystokinin octapeptide secondary to theoretically increased central cholecystokinin tetrapeptide activity.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011949 Receptors, Cholecystokinin Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood. CCK Receptors,Caerulein Receptors,Cholecystokinin Octapeptide Receptors,Cholecystokinin Receptors,Pancreozymin Receptors,Receptors, CCK,Receptors, Caerulein,Receptors, Pancreozymin,Receptors, Sincalide,Sincalide Receptors,CCK Receptor,CCK-4 Receptors,CCK-8 Receptors,Cholecystokinin Receptor,Receptors, CCK-4,Receptors, CCK-8,Receptors, Cholecystokinin Octapeptide,CCK 4 Receptors,CCK 8 Receptors,Octapeptide Receptors, Cholecystokinin,Receptor, CCK,Receptor, Cholecystokinin,Receptors, CCK 4,Receptors, CCK 8
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012844 Sincalide An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas. CCK-8,Cholecystokinin Octapeptide,CCK-OP,Cholecystokinin Pancreozymin C-Terminal Octapeptide,H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,Kinevac,OP-CCK,SQ-19,844,SQ-19844,Syncalide,Cholecystokinin Pancreozymin C Terminal Octapeptide,SQ 19,844,SQ 19844,SQ19,844,SQ19844
D013758 Tetragastrin L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. CCK-4,Cholecystokinin-Tetrapeptide,Gastrin Tetrapeptide,AOC-Tetragastrin,AOC-Tetrapeptide,CCK (30-33),CKK-4,Cholecystokinin (30-33),Cholecystokinin 4,AOC Tetragastrin,AOC Tetrapeptide,Cholecystokinin Tetrapeptide,Tetrapeptide, Gastrin

Related Publications

R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Lymphocyte cholecystokinin concentrations in panic disorder.
July 1993, The American journal of psychiatry,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
March 2000, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects.
November 1996, The American journal of psychiatry,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.
February 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Cholecystokinin and panic disorder.
April 2004, Acta neuropsychiatrica,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Frequency of DSM-III personality disorders in patients with panic disorder: comparison with psychiatric and normal control subjects.
October 1988, Psychiatry research,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder.
June 1991, Biological psychiatry,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.
August 1996, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Gene variations in the cholecystokinin system in patients with panic disorder.
April 2010, Psychiatric genetics,
R B Lydiard, and J C Ballenger, and M T Laraia, and M D Fossey, and M C Beinfeld
Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder.
January 2004, Journal of neural transmission. Supplementum,
Copied contents to your clipboard!